key: cord-0049797-qpjjlb9l authors: Migliaro, Fiorella; Salomè, Serena; Corsini, Iuri; De Luca, Daniele; Capasso, Letizia; Gragnaniello, Diego; Raimondi, Francesco title: Neonatal lung ultrasound: from paradox to diagnosis …and beyond date: 2020-09-10 journal: Early Hum Dev DOI: 10.1016/j.earlhumdev.2020.105184 sha: 9c4712642c8e611b94cf40c8a5cc238e95eaa960 doc_id: 49797 cord_uid: qpjjlb9l nan Combining images from anatomic structures and artifacts (i.e. reproducible images that have no anatomic equivalent), clinical researchers have created ultrasound profiles. These, in turn, have been validated as diagnostic markers of several important respiratory diseases both in adult and in the developing age [1] . One important assumption is that artifacts appear and change in a reproducible parallel with the air to fluid ratio, spanning from a normally aerated to a fully consolidated lung parenchyma (Fig.2) . The details of this approach applied to neonatal respiratory medicine are well described in recent reviews [2, 3] . The present paper is a brief summary of the key points, an update of the most recent results and a speculation on promising research in neonatal lung ultrasound (LUS). The original strategy pursued by neonatal clinical investigators was to validate ultrasound profiles describing the main infantile respiratory diagnoses [2] . In a series of 124 neonates, Corsini I et al found that the concordance between LUS and chest X ray (CXR) diagnosis was 91% (95% CI 86-96%). The median time to diagnosis was shorter for LUS (9.5 min, IQR 5-15) than for CXR (50 min, IQR 33-64) (p<0.0001) [4] . In an international study, the recognition of the ultrasound profile typical of tension pneumothorax was achieved with absolute diagnostic accuracy and a successful emergency drainage was performed before the CXR diagnosis in 9/42 cases [5]. Besides making a diagnosis, LUS can be applied to clinical situations evolving over time. These functional applications of neonatal LUS stem from the significant correlation between lung aeration and a reproducible sequence of artifacts (Fig 2) . When the latter is given a score, neonatal LUS becomes a reliable tool to monitor post natal transition (6), the need for non invasive respiratory support [7] and surfactant administration [8] . p<0.0001) [10] . In a quality improvement project, Raschetti R et al compared surfactant administration based on the FiO 2 = 0.3 limit with a second period when the LUS score threshold from the previous paper was added to oxygen requirement as an alternative treatment criterion. While the total number of infants receiving surfactant remained unchanged, in the second period a significantly higher number of babies received surfactant within 3 hours of life [11] . According to available evidence [12] , an early treatment is protective against bronchopulmonary dysplasia (BPD). Other single center studies have recently confirmed these results. In a series of 45 preterm infants less than 34 weeks gestational age, Vardar G et al demonstrated that a cut-off LUS score = 4 predicted the need for surfactant with 96% sensitivity and 100% specificity [13]. Describing a single NICU yearly experience, Gregorio-Hernandez R et al showed that LUS predicted surfactant treatment with an AUC= 0.97 [14] . Similar results (AUC= 0.94) came from the study by Perri A and coworkers on 56 infants less than 31 weeks gestational age [15] . Recently, Rodriguez Fanjul J et al published the first RCT on the topic. Fifty-six preterm neonates were randomized to receive surfactant on the basis of a LUS cut-off score and/or J o u r n a l P r e -p r o o f Journal Pre-proof FiO 2 >0.3 or on the oxygen requirement alone. The first group received a significantly earlier treatment with a better oxygenation as measured by the SpO 2 / FiO 2 ratio [16] . The most widely accepted definition of BPD consists in oxygen dependency at 36 weeks post menstrual age. As BPD is a significant and often invalidating long term sequel of prematurity, its reliable prediction early in NICU admission would give clinicians time to prepare effective counter measures. Abdelmawla M et al described a small retrospective cohort where a LUS score = 6 had a remarkable performance (sensitivity=78% and specificity=97%; PPV=95% and NPV=82%) in predicting BPD [17] . In a cohort of 59 VLBW infants (median PMA = 29 weeks), Alonso-Ojembarrena A et al showed that a LUS score ≥5 at 2 weeks post-natal age (i.e. PMA = 31 weeks) predicted BPD with an AUC=0.93 [18] . Similar results were recently published by Oulego-Erroz I and coworkers on 42 preterm infants [19] . A LUS score ≥8 at 7 days of life predicted severe BPD (i.e. FiO2 ≥0.3 or positive pressure ventilation at 36 weeks PMA) with an AUC =0.94. Most of the published evidence comes from small, single centers studies with minor protocol variations. There is an objective need for standardization and collaborative studies to render LUS a daily tool in neonatal respiratory medicine [20] . A complementary strategy relies on computer-assisted, big data technology which grants speed of interpretation and generalization of the results. The use of machine learning, deep learning or convoluted neural networks systems has already obtained results comparable to those achieved by expert human operators both in adult and neonatal LUS [21, 22] . In summary, researchers have overcome a physical paradox exploiting ultrasound artifacts for clinical purposes. New technologies promise to boost this achievement for routine use in critical care. Fig.1 . Number of papers retrieved from the PubMed database using "lung ultrasound" (dark grey columns) and "neonate" AND "lung ultrasound" (light grey columns) keywords, respectively. A semiquantitative LUS score reliably parallels lung aeration and oxygenation. Each lung is divided into 3 areas and for each areas a score from 0 to 3 is assigned. Score values correspond to 4 different pattern: (A) horizontal lines (aka A lines) represent the normally aerated lung parenchyma (score 0). A progressively increasing fluid to air ratio (B) is seen as vertical hyperechoic artifacts (aka B lines) (score 1). Confluent and crowded B lines (C) create a "white lung image" (score 2). A minimal air content is visualized as lung echodensity equal to that of the liver (D) called "consolidation areas" (score 3). J o u r n a l P r e -p r o o f Lung Ultrasound for Critically Ill Patients Point-of-care lung ultrasound in neonatology: classification into descriptive and functional applications Lung ultrasound in the neonatal intensive care unit: Review of the literature and future perspectives Can neonatal lung ultrasound monitor fluid clearance and predict the need of respiratory support? Use of neonatal chest ultrasound to predict noninvasive ventilation failure Lung Ultrasonography Score to Evaluate Oxygenation and Surfactant Need in Neonates Treated With Continuous Positive Airway Pressure A Multicenter Lung Ultrasound Study on Transient Tachypnea of the Neonate Improve Timeliness of Surfactant Replacement: A Quality Improvement Project Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome Lung ultrasound in preterm infants with respiratory distress: experience in a neonatal intensive care unit Lung ultrasonography score versus chest X-ray score to predict surfactant administration in newborns with respiratory distress syndrome Early surfactant replacement guided by lung ultrasound in preterm newborns with RDS: the ULTRASURF randomised controlled trial A Lung Ultrasound Severity Score Predicts Chronic Lung Disease in Preterm Infants Lung ultrasound score as early predictor of bronchopulmonary dysplasia in very low birth weight infants Early assessment of lung aeration using an ultrasound score as a biomarker of developing bronchopulmonary dysplasia: a prospective observational study Clinical Data Are Essential to Validate Lung Ultrasound Visual assessment versus computer-assisted gray scale analysis in the ultrasound evaluation of neonatal respiratory status Deep Learning for Classification and Localization of COVID-19 Markers in Point-of-Care Lung Ultrasound The authors acknowledge the support of NeoLUS, a collaborative study group on Neonatal Lung UltraSound (cfr https:// www.facebook.com /groups/ 1493243264284547).